 |
Prospector
Profile
926-06
|
| |
| Davi Skin, Inc. |
NAICS |
325412 |
| 4223 Glencoe Avenue, Suite B130
Marina Del Rey, CA 90292 |
Description |
Skin Care Products Mfg. |
| (310) 827-0800 |
Employees |
5 |
| http://www.daviskin.com/ |
Revenue |
(mil) |
0.0230 |
| |
Income |
(mil) |
-3.7790 |
| |
Assets |
(mil) |
1.6150 |
| |
Liability |
(mil) |
0.5600 |
| |
(for the year ended 2006-12-31) |
| |
|
Category:
Loss/Deficit
|
| |
|
Event:
Davi Skin, Inc. had a net loss of $942,916 for the second quarter ended June 30, 2007, higher than the $697,980 net loss reported during the second quarter of last year. For the six months ended June 30, 2007, the Company had a $2,329,262 net loss, lower than the $2,821,479 net loss booked in the first half of 2006. The Company balance sheet at June 30, 2007 showed an accumulated deficit of $2,329,262 and stockholders' deficit of $148,217. It also has strained liquidity with $759,716 in total current assets available to pay $781,109 in total current liabilities.
|
| |
|
Intellectual Property:
At the core of all the Company's products is a proprietary microencapsulated anti-aging antioxidant complex called Meritage that was created in collaboration with laboratories in Lyon, France. [SEC Filing 10-KSB 04-17-07]
|
| |
|
Description:
The Company develops, manufactures, and distributes skin care products for men and women in the United States.
|
| |
|
Officers:
Carlo Mondavi (Chair); Joseph Spellman (Pres., CEO & Dir.); Josh LeVine (Sec., Treas. & Dir.); Munjit Johal (CFO)
|
| |
|
Auditor:
Child Van Wagoner & Bradshaw PLLC
|
| |
|
Securities:
Common Stock-Symbol DAVN.OB; OTC BB;
16,661,208 common shares outstanding as of August 17, 2007.
|
| |
| |
| |
| return to main page |
|
|
